DeGette Calls on Major Insulin Manufacturers to Answer Questions Regarding Access to Insulin
October 02, 2024
October 02, 2024
WASHINGTON, Oct. 2 -- Rep. Diana DeGette, D-Colorado, issued the following news release:
This week, Diabetes Caucus Co-Chairs Congresswoman Diana DeGette (CO-01) and Congressman Gus Bilirakis (FL-12) sent letters to the three largest insulin producers urging them to answer questions regarding access to insulin. The letters were sent to Eli Lilly, Novo Nordisk, and Sanofi.
"These companies have long provided lifesaving and life-enhancing products to over 38 million . . .
This week, Diabetes Caucus Co-Chairs Congresswoman Diana DeGette (CO-01) and Congressman Gus Bilirakis (FL-12) sent letters to the three largest insulin producers urging them to answer questions regarding access to insulin. The letters were sent to Eli Lilly, Novo Nordisk, and Sanofi.
"These companies have long provided lifesaving and life-enhancing products to over 38 million . . .